Who owns Cyclacel Pharmaceuticals Inc?
- Ticker: BGMS
- CUSIP Number: 23254l876
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclacel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cyclacel Pharmaceuticals stock
Who bought or sold Cyclacel Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 23k | $33k | 100% | Dec 2025 |
|
| Citadel Advisors | 22k | $22k | 100% | Mar 2026 |
|
| Geode Capital Management | 22k | $22k | 100% | Mar 2026 |
|
| Tower Research Capital | 3.0k | $4.5k | 181% | Dec 2025 |
|
| UBS Group | 2.2k | $2.2k | 271% | Mar 2026 |
|
| SBI Securities | 500.00 | $500.000000 | 24900% | Mar 2026 |
|
| Archer Investment Corp | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Cyclacel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Dec 2025 | 28k | $41k |
| DRW Holdings | Dec 2025 | 25k | $37k |